TP53, as the most common mutation in the high-risk group, has been reported to be associated with undesirable biological behaviors including high AFP, advanced tumor stage, vascular invasion, poor tumor differentiation, and poor Child-Pugh class (Long et al., 2019). This evidence concerns the gene AFP and neoplasm.